Main characteristics of the included studies.

<div><p>Background</p><p>In the treatment of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSIs), vancomycin stands as the prevalent therapeutic agent. Daptomycin remains an alternative antibiotic to treat MRSA BSIs in cases where vancomycin prove...

Full description

Saved in:

Bibliographic Details
Main Author:	Yau Adamu (18004386) (author)
Other Authors:	Mireia Puig-Asensio (4521145) (author), Bashir Dabo (5504444) (author), Marin L. Schweizer (16441374) (author)
Published:	2024
Subjects:	Medicine Microbiology Cell Biology Genetics Biotechnology Developmental Biology Cancer Infectious Diseases Virology Computational Biology prevalent therapeutic agent pooled odd ratios newcastle ottawa scale systematic literature review staphylococcus aureus </ revised cochrane risk vancomycin proves ineffective daptomycin within 3 treat mrsa bsis resistant staphylococcus aureus vancomycin among patients early daptomycin use stratified analysis based xlink "> compared randomized control studies xlink "> priori </ existing literature cochrane library daptomycin early included based early switch analyses based whether daptomycin daptomycin remains daptomycin demonstrated vancomycin treatment twenty studies time patients significant association set inclusion rob 2 randomized trials prospective studies mrsa strains lower odds individual observational including embase five days exclusion criteria decreased odds bloodstream infections bias tool another anti alternative antibiotic 5 days 06 ).
Tags:	Add Tag No Tags, Be the first to tag this record!

Main characteristics of the included studies.

Similar Items